Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services

Categories

Latest Blog Posts

Featured image for “Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)”

April 19, 2024

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
April 17, 2024 Download PDF New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis…
MS Drug Therapies
Featured image for “Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis”

April 19, 2024

Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

  • MS Drug Therapies
    /
Apr 18, 2024 PDF Version NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), announced that…
MS Drug Therapies
Featured image for “Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis”

April 17, 2024

Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Apr 17, 2024 EAST HANOVER, N.J., April 17, 2024 — Novartis today announced data from the ALITHIOS open-label extension study showing sustained…
MS Drug Therapies

April 17, 2024

Apr 16, 2024 – Press Release: Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Media / Press Releases Tuesday, Apr 16, 2024 Results from the Phase III study showed that subcutaneous (SC) injection was consistent with…
MS Drug Therapies
Featured image for “OrCam Assistive Smart Cameras For Impaired Sight and Reading Difficulties”

April 11, 2024

OrCam Assistive Smart Cameras For Impaired Sight and Reading Difficulties

  • Accessibility
    /
Do you or someone you know have difficulty seeing or reading? The most advanced tool for vision loss and reading…
Accessibility
Featured image for “The Recording Studio Helped This MS Neurologist Through Tough Pandemic Times Now He Has a New Album to Show for It”

April 8, 2024

The Recording Studio Helped This MS Neurologist Through Tough Pandemic Times Now He Has a New Album to Show for It

  • Inspirational
    /
  • Mental Health
    /
  • Misc. Entertainment
    /
Dr. Stephen Krieger uses a mix of keyboards, drum machines, and samplers to produce his music. By Caitlin Heaney West…
Inspirational
Featured image for “Foot Drop: Everything You Need To Know”

April 5, 2024

Foot Drop: Everything You Need To Know

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Foot drop refers to a condition when a person is unable to lift the front part of their foot to the…
Multiple Sclerosis

April 4, 2024

Viatris and Mapi Pharma Statement Regarding New Drug Application for GA Depot

  • MS Drug Therapies
    /
Viatris Inc. has been informed that Mapi Pharma Ltd. has received a Complete Response Letter (CRL) regarding the New Drug…
MS Drug Therapies

April 2, 2024

VISIT The MS GYM!

  • Wellness for MS
    /
Congratulations on stepping towards a better life with MS (or any neurological condition). The MS Gym community and resources will…
Wellness for MS

April 2, 2024

Women’s Adaptive Jeans designed for Wheelchair Users

  • Accessibility
    /
Women’s denim brand NYDJ, known for slimming jeans designed for a range of body types, is the latest mainstream brand…
Accessibility

Categories

Latest Blog Posts